Home>Topics>>NPS Pharmaceuticals and Takeda Revise Agreements (Transcript)
NPS Pharmaceuticals and Takeda Revise Agreements (Transcript)
Healthcare Sector and Stocks Analysis from Seeking Alpha
Tue, 19 Mar 2013
NPS Pharmaceuticals Inc. ( NPSP ) NPS Pharmaceuticals and Takeda Revise Agreements Conference Call March 19, 2013 8:30 AM ET Executives Susan Mesco – Corporate Communications Francois Nader – President and CEO Eric Pauwels – SVP and Chief Commercial Officer Luke Beshar – EVP and CFO Analysts Alan ...
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.